Plasma immunoreactive glucagon fractions in four cases of glucagonoma: Increased “Large glucagon — immunoreactivity”
Open Access
- 1 August 1976
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 12 (4), 319-326
- https://doi.org/10.1007/bf00420975
Abstract
Immunoreactive glucagon (IRG) fractions from plasma of 8 normal subjects and 4 patients with glucagon secreting tumors were studied by gel filtration techniques on Bio Gel P-30 and Sephadex G-50 columns. The pancreatic glucagon specific anti serum (30K) of Unger was utilized to measure IRG. Columns were calibrated with labelled albumin, proinsulin, insulin and glucagon. Four peaks were defined in normal and tumor bearing patients: peak I (>20000 mol. wt.), peak II (primarily 9000 mol. wt.), peak III pancreatic glucagon (3500 mol. wt.) and peak IV small glucagon (<3500 mol. wt.). Glucagonoma patients differed from our normal and reported normal subjects in that peak II contained most of the circulating IRG. The percent of IRG associated with peak II was 9.5–31.5% in normals and 39.1–61.2% in glucagonomas. Glucagon-like biological activity in an isolated hepatocyte system was demonstrated for all peaks. However, relative to immunoreactivity, peak II showed reduced activity (25–33%). Immunoassay of dilutions of all peaks revealed the probability of immuno determinants identical with porcine pancreatic glucagon. The presence of heterogeneous IRG peaks with biological glucagon-like activity suggest that the larger molecules may be prohormones. Further, it is possible that specific elevation of peak II may be a diagnostic feature of glucagonomas.Keywords
This publication has 21 references indexed in Scilit:
- Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogsMetabolism, 1975
- Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinomaAmerican Journal Of Medicine, 1975
- A GLUCAGONOMA SYNDROMEThe Lancet, 1974
- Cure of insulin-dependent diabetes mellitus by removal of a glucagonoma.BMJ, 1974
- Glucagon control of cyclic AMP accumulation in isolated intact rat liver parenchymal cells in vitroBiochimica et Biophysica Acta (BBA) - General Subjects, 1974
- “Big, big insulin”Metabolism, 1973
- Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive functionGut, 1971
- TREATMENT OF MULTIPLE-HORMONE-PRODUCING MALIGNANT ISLET-CELL TUMOUR WITH STREPTOZOTOCINThe Lancet, 1968
- The isolation of insulin from a single cat pancreasBiochimica et Biophysica Acta, 1962
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962